Éjaculation prématurée: définition, physiopathologie, traitements

Waldinger MD, Hengevel MW, Zwinderman AH et al. (1994) Paroxetine treatment of premature ejaculation; a double blinded, randomized, placebo-controlled study. Am J Psychiatry 151: 1377–1379

Bieber I (1974) The psychoanalytic treatment of sexual disorders. J Sex Marital Ther 1: 5–15

Marson L (1994) Serotoninergic neurotoxic lesions facilitate males’ sexual reflexes. Pharmacol Biochem Behav 47: 883–888

Heaton JP (2000) Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine. Neurosci Behav Rev 24: 561–569

Xin ZC (1996) Penile sensitivity in patients with primary premature ejaculation. J Urolı 56: 979–981

Waldinger MD (2002) The neurobiological approach to premature ejaculation. J Urol 168: 2359–2367

Screponi E (2001) Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58: 198–202

Carani C, Isidori AM, Granata A, et al. (2005) Multi center study on the prevalence of sexual symptoms in male hypo-and hyperthyroid patients. J Clin Endocrinol Metab 90: 6472–6479

Janini E, Carosa E, Pepe M, et al. (2006) Update on pathophysiology of premature ejaculation. EAU update series 4: 141–149

Mancina R (2005) Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 11: 107–115

Waldinger MD, Zwinderman AH, Schweitzer DH, et al. (2004) Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16: 369–381

Hamilton L (1993) Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono-and di-desmethyl metabolites in human plasma using column-switching high performance liquid chromatography. J Chromatogr 612: 253–261

Hawton K (1986) Prognostic factors in sex therapy. Behav Res Ther 24: 377–385